BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
31002287
Number of visits today
5522
Number of downloads
13536941
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Zheng J, Wu J, Ding X, Shen HC, Zou G. Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors. Bioorg Med Chem Lett 2021;38:127862. [PMID: 33609659 DOI: 10.1016/j.bmcl.2021.127862] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Liu Y, Han X, Zou G, Zhu W, Shen H, Liu H. Small molecule approaches to treat autoimmune and inflammatory diseases (Part II): Nucleic acid sensing antagonists and inhibitors. Bioorg Med Chem Lett 2021;44:128101. [PMID: 33984476 DOI: 10.1016/j.bmcl.2021.128101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sabnis RW. Thienopyridinyl and Thiazolopyridinyl Compounds as IRAK4 Inhibitors. ACS Med Chem Lett 2021;12:532-3. [PMID: 33859790 DOI: 10.1021/acsmedchemlett.1c00147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sabnis RW. Novel Substituted Exomethylene-oxindoles as HPK1 Inhibitors. ACS Med Chem Lett 2021;12:681-2. [PMID: 34055207 DOI: 10.1021/acsmedchemlett.1c00172] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zheng J, Chen D, Xu J, Ding X, Wu Y, Shen HC, Tan X. Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes. Bioorg Med Chem Lett 2021;48:128229. [PMID: 34214508 DOI: 10.1016/j.bmcl.2021.128229] [Reference Citation Analysis]
5 García-Merino A. Bruton's Tyrosine Kinase Inhibitors: A New Generation of Promising Agents for Multiple Sclerosis Therapy. Cells 2021;10:2560. [PMID: 34685540 DOI: 10.3390/cells10102560] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yaldizli Ö, Derfuss T. All Bruton's tyrosine kinase inhibitors have similar efficacy and risks: Commentary. Mult Scler 2022;:13524585221097562. [PMID: 35546510 DOI: 10.1177/13524585221097562] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345